Nuo Therapeutics, Inc.: Form 10-K for the period ended Dec 31, 2015
Filed with the SEC on Oct 24, 2016 and accepted by EDGAR at Oct 21, 2016, 19:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2015-01-01 to 2015-12-31 | $11.5m | us-gaap:Revenues |
| Cost of revenue | 12 months2015-01-01 to 2015-12-31 | $8.0m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2015-01-01 to 2015-12-31 | $3.5m | us-gaap:GrossProfit |
| Research and development | 12 months2015-01-01 to 2015-12-31 | $2.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2015-01-01 to 2015-12-31 | −$41.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2015-01-01 to 2015-12-31 | −$89.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2015-01-01 to 2015-12-31 | −$52.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2015-01-01 to 2015-12-31 | −$0.42 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2015-01-01 to 2015-12-31 | −$14.4m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2015-01-01 to 2015-12-31 | $698.2k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2015-12-31 | $922.3k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-12-31 | $3.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-12-31 | $7.1m | us-gaap:Assets |
| Current liabilities | At period end2015-12-31 | $42.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-12-31 | $43.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2015-12-31 | −$36.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001144204-16-129029. Last ingested by Listed: Nov 14, 2026, 23:44 ET. Listed shows no prices and gives no investment advice.